PDCD1 and hepatocellular carcinoma: However, our analysis showed no significant differences in TMB between patients with HCC with high and low CD28+PD-1+ Tc-cell enrichment, suggesting that the immune characteristics of this subset are driven more by phenotypic changes than by mutated genes.